Schilke Tobin (CIK 1678984) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell CRNX (71,471 shares), Sell CRNX (7,956 shares), Buy CRNX (471 shares), Sell CRNX (6,713 shares), Buy CRNX (32,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Financial & Infra. Ofcr. | Sell | 71,471 | $6.1M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Financial & Infra. Ofcr. | Sell | 7,956 | $676,260 |
| 2026-08-24 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Financial & Infra. Ofcr. | Buy | 471 | $0 |
| 2026-03-04 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Financial Officer | Sell | 6,713 | $266,305 |
| 2026-02-25 | Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Financial Officer | Buy | 32,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01